Fig. 5.
Fig. 5. Effects of genistein and staurosporine on PMA and fMLP stimulation of human neutrophils. (A) Neutrophils (106) were pretreated without or with increasing concentrations of staurosporine for 20 minutes before stimulation with 100 ng/mL PMA for 20 minutes (○) or 0.5 μmol/L fMLP for 5 minutes (•) and determination of SOD-inhibitable cytochrome c reduction. (B) Neutrophils (106) were pretreated with or without 100 μmol/L genistein before stimulation with 100 ng/mL PMA for 20 minutes or 5 × 10-7 mol/L fMLP for 5 minutes and determination of SOD-inhibitable cytochrome c reduction. Results are the average of duplicate determinations. Control absorbances were: (A) unstimulated cells, 0.336 ± 0.013; PMA-treated, 0.931 ± 0.005; fMLP-treated, 0.754 ± 0.008. (B) Unstimulated cells, 0.386 ± 0.005; PMA-treated, 0.606 ± 0.015; fMLP-treated 0.540 ± 0.007.

Effects of genistein and staurosporine on PMA and fMLP stimulation of human neutrophils. (A) Neutrophils (106) were pretreated without or with increasing concentrations of staurosporine for 20 minutes before stimulation with 100 ng/mL PMA for 20 minutes (○) or 0.5 μmol/L fMLP for 5 minutes (•) and determination of SOD-inhibitable cytochrome c reduction. (B) Neutrophils (106) were pretreated with or without 100 μmol/L genistein before stimulation with 100 ng/mL PMA for 20 minutes or 5 × 10-7 mol/L fMLP for 5 minutes and determination of SOD-inhibitable cytochrome c reduction. Results are the average of duplicate determinations. Control absorbances were: (A) unstimulated cells, 0.336 ± 0.013; PMA-treated, 0.931 ± 0.005; fMLP-treated, 0.754 ± 0.008. (B) Unstimulated cells, 0.386 ± 0.005; PMA-treated, 0.606 ± 0.015; fMLP-treated 0.540 ± 0.007.

Close Modal

or Create an Account

Close Modal
Close Modal